FdaApplication
ANDA 211086
Identifiers
- fda_app_no: ANDA211086
Properties
| Property | Value |
|---|---|
| applicant_name | EXELA PHARMA SCIENCES LLC |
| application_type | ANDA |
| approval_date | 2020-09-17 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ERYTHROMYCIN LACTOBIONATE | ERYTHROMYCIN LACTOBIONATE | EQ 500MG BASE/VIAL | INJECTABLE;INJECTION |
1 product